Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patient

Clinical and Experimental Immunology

Volumn 135, Issue 1, 2004, Pages 74-84

  Banga, J P ^a   Moore, J K ^b   Duhindan, N ^a   Madec, A M ^c   Van Endert, P M ^c   Orgiazzi, J ^d   Endl, J ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

^c INSERM   (France)

^d INSERM U580 ^*

Author keywords

Antigen specific B cells; Autoimmunity; GAD65; HLA DM; T cells

Indexed keywords

ENZYME; EPITOPE; GLUTAMATE DECARBOXYLASE 65; HLA DM ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ANTIGENIC VARIATION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; INTRACELLULAR MEMBRANE; MEDICAL ASSESSMENT; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIGEN PRESENTATION; ANTIGENS, SURFACE; AUTOIMMUNITY; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENDOCYTOSIS; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; GLUTAMATE DECARBOXYLASE; HERPESVIRUS 4, HUMAN; HLA-D ANTIGENS; HUMANS; IMMUNOGLOBULIN G; ISOENZYMES; MICROSCOPY, FLUORESCENCE;

EID: 0347949511     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02343.x     Document Type: Article

References (34)

1. Lernmark A. Glutamic acid decarboxylase - gene to antigen to disease. J Int Med 1996; 240:259-77.
2. Powers AC, Bavik K, Tremble J, Daw K, Scherbaum WA, Banga JP. Comparative analysts of epitope recognition of glutamic acid decarboxylase by autoantibodies from different autoimmune disorders. Clin Exp Immunol 1999; 118:349-56.
3. Nepom GT. Class II antigens and disease susceptibility. Ann Rev Med 1995; 46:17-25.
4. Endl J, Otto H, Jung G et al. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J Clin Invest 1997; 99:2405-15.
5. Bach JM, Otto H, Nepom GT et al. High affinity presentation of an autoantigenic peptide in type 1 diabetes by an HLA class II protein encoded in a haplotype protecting from disease. J Autoimmun 1997; 10:375-86.
6. Schloot NC, Batstra MC, Duinkerken G et al. GAD65 reactive T cells in a non-diabetic stiff-man syndrome patient. J Autoimmun 1999; 12:289-96.
7. Wicker LS, Chen SL, Nepom GT et al. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J Clin Invest 1996; 98:2597-603.
8. Patel SD, Cope AP, Cognia M et al. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR (alphal*0101,beta1*0401) transgenic mice. Proc Natl Acad Sci USA 1997; 94:8082-7.
9. Schwartz H, Chandonia JM, Kash S et al. High-resolution autoreactive epitope mapping and structural modeling of the 65 KDa form of human glutamic acid decarboxylase. J Mol Biol 1999; 287:983-99.
10. Myers MA, Davies JM, Tong JC et al. Conformational epitopes on the diabetes autoantigen GAD65 identified by peptide phage display and molecular modeling. J Immunol 2000; 165:3830-8.
11. Richter W, Endl J, Eiermann TH et al. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. Proc Natl Acad Sci USA 1992; 89:8467-71.
12. Madec AM, Rousset F, Ho S et al. Four IgG anti-islet human monoclonal antibodies isolated from a type 1 diabetes patient recognize distinct epitopes of glutamic acid decarboxylase 65 and are somatically mutated. J Immunol 1996; 156:3541-9.
13. Syren K, Lindsay L, Stoehrer B et al. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase. J Immunol 1996; 157:5208-14.
14. Tremble J, Morgenthaler NG, Vlug A et al. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a non-diabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in Type I diabetes. J Clin Endocrinol Metab 1997; 82:2664-70.
15. Sohnlein P, Muller M, Syren K et al. Epitope spreading and a variety but not disease specific GAD65 antibody response in type 1 diabetes. Diabetologia 2000; 43:210-7.
16. Fallone M, Lee J, Patstone G, Yeung B, Sarvetnick N. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J Immunol 1998; 161:1163-8.
17. Serreze DV, Fleming SA, Chapman HD, Richard SD, Leiter EH, Tisch, RM. B lymphocytes are critical antigen presenting cells for the initiation of T cell mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 1999; 151:3912-8.
18. Noorchasm H, Lieu YK, Noorchasm N et al. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. J Immunol 1999; 163:143-750.
19. Hulbert CB, Riseili M, Rojas M, Thomas JW. B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice. J Immunol 2001; 167:5535-8.
20. Martin S, Wolf-Eichbaum D, Duikerken G et al. Development of type 1 diabetes despite severe hereditary B cell deficiency. New Engl J Med 2001; 345:1036-40.
21. Lanzavecchia A. How can cryptic epitopes trigger autoimmunity. J Exp Med 1995; 181:1945-8.
22. Amigorena S, Bonnerot C. Role of B cell and Fc receptors in the selection of T cell epitopes. Curr Opin Immunol 1998; 10:88-92.
23. Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med 1995; 181:1957-63.
24. Watts C, Antoniou A, Manoury B et al. Modulation by epitope specific antibodies of class II MHC restricted presentation of the tetanus toxin antigen. Immunol Rev 1998; 164:11-6.
25. Brocke P, Garbi N, Momburg F, Hammerling GJ. HLA-DM, HLA-DO and tapasin: functional similarities and differences. Curr Opin Immunol 2002; 14:22-9.
26. Reijonen H, Daniels TL, Lernmark Ä, Nepom GT. GAD65-specific autoantibodies enhance the presentation of an immunodominant T cell epitope from GAD65. Diabetes 2000; 49:1621-6.
27. Jaume JC, Parry SL, Madec AM, Sonderstrup G, Baekkeskov S. Suppressive effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope. J Immunol 2002; 169:665-72.
28. Roep BO, Atkinson MA, van Endert PM et al. Autoreactive T cell responses in insulin dependent (type 1) diabetes mellitus. Report of the First International Workshop for Standardization of T cell Assays. J Autoimmun 1999; 13:267-82.
29. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature 1985; 314:537-9.
30. Bertrand F, Chafforte AF, Djavadi-Ohaniance L, Goldberg ME. Measurements of the true affinity constant solution of antigen-antibody complexes by enzyme linked immunosorbent assay. J Immunol Meth 1984; 77:305-19.
31. Reijonen H, Elliot JF, van Endert PM, Nepom GT. Differential presentation of glutamic acid decarboxylase 65 (GAD 65) T cell epitopes among HLA-DRB1*0401 positive individuals. J Immunol 1999; 163:1674-81.
32. Chen X, Laur O, Kambayashi T et al. Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development. J Exp Med 2002; 195:1053-62.
33. Arndt SO, Vogt AB, Markovic-Plese S et al. Functional HLA-DM on the surface of B cells and immature dendritic cells. EMBO J 2000; 19:1241-51.
34. Evavold BD, Allen PM. Separation of IL-4 production from proliferation by an altered T cell receptor ligand. Science 1991; 252:1308-10.